Top compounds associated with response to LYPD1


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus FIMM pan-cancer AAC 0.004 1
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.0014 1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.00091 1
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00084 1
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.00073 1
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0008 1
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.00067 1
mRNA TL-1-85 GDSC1000 pan-cancer AAC -0.00048 1
mRNA BEC CTRPv2 pan-cancer AAC -0.0011 1
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.0011 1
Download CSV